SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cardio Diagnostics Holdings, Inc. – ‘DEL AM’ on 1/29/24

On:  Monday, 1/29/24, at 12:53pm ET   ·   Effective:  1/29/24   ·   Accession #:  1079973-24-133   ·   File #:  333-276725

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/29/24  Cardio Diagnostics Holdings, Inc. DEL AM      1/29/24    1:7K                                     Edgar Tech & Bus… Inc/FA

Registration Effectiveness-Delaying Amendment

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DEL AM      Registration Effectiveness-Delaying Amendment       HTML      6K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



Cardio Diagnostics Holdings, Inc.

411 W. Superior Street, Suite 444

Chicago, IL 60654

 

 

January 29, 2024

 

 

VIA EDGAR

Division of Corporation Finance

Office of Life Sciences

U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549

 

Re:

Cardio Diagnostics Holdings, Inc.

Registration Statement on Form S-3

File No. 333-276725

Ladies and Gentlemen:

Please accept this letter as a delaying amendment to the above-referenced Registration Statement on Form S-3 filed by Cardio Diagnostics Holdings, Inc. (the “Company”) with the Securities and Exchange Commission on January 26, 2024 to include the delaying amendment language required by Rule 473 of the Securities Act of 1933, as amended, as follows:

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such dates as the Commission, acting pursuant to said section 8(a), may determine.”

The Company requests that the Staff contact Rupert Russell at (415) 425-5839 with any questions or comments.

 

 

Very truly yours,

 

CARDIO DIAGNOSTICS HOLDINGS, INC.

   
   
   By:         /s/ Elisa Luqman
    Elisa Luqman
Chief Financial Officer

 

cc:

P. Rupert Russell, Esq.

Shartsis Friese LLP

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘DEL AM’ Filing    Date    Other Filings
Filed on / Effective on:1/29/24
1/26/24S-3
 List all Filings 
Top
Filing Submission 0001079973-24-000133   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 11:34:24.1pm ET